ADENOVERSE Trademark

Trademark Overview


On Tuesday, January 31, 2023, a trademark application was filed for ADENOVERSE with the United States Patent and Trademark Office. The USPTO has given the ADENOVERSE trademark a serial number of 97774473. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2024. This trademark is owned by Precigen, Inc.. The ADENOVERSE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services, namely, providing medical therapy treatments for patients in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular diseases

Scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of complex diseases; medical research in the field of immunotherapy
adenoverse

General Information


Serial Number97774473
Word MarkADENOVERSE
Filing DateTuesday, January 31, 2023
Status700 - REGISTERED
Status DateTuesday, February 20, 2024
Registration Number7309764
Registration DateTuesday, February 20, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesMedical services, namely, providing medical therapy treatments for patients in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular diseases
Goods and ServicesScientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of complex diseases; medical research in the field of immunotherapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 17, 2023
Primary Code042
First Use Anywhere DateSaturday, December 31, 2016
First Use In Commerce DateSaturday, December 31, 2016

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 17, 2023
Primary Code044
First Use Anywhere DateSaturday, December 31, 2016
First Use In Commerce DateSaturday, December 31, 2016

Trademark Owner History


Party NamePrecigen, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGermantown, MD 20876

Party NamePrecigen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGermantown, MD 20876

Party NamePrecigen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGermantown, MD 20876

Trademark Events


Event DateEvent Description
Friday, February 3, 2023NEW APPLICATION ENTERED
Friday, February 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 30, 2023ASSIGNED TO EXAMINER
Monday, October 30, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, October 30, 2023EXAMINERS AMENDMENT E-MAILED
Monday, October 30, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 30, 2023EXAMINER'S AMENDMENT ENTERED
Monday, October 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 20, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, September 24, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED